CD4 and neoplasm: Our study found that increased infiltration of TILBs was associated with good prognosis, and TILBs might promote antitumor immunity in multiple ways, including presentation of tumor antigens to CD4+ T cells [48, 49] or enhancing antitumor immunity by producing tumor-specific antibodies [50, 51].